JITC

Soluble PD-L1 as an early marker of progressive disease on nivolumab
Kathleen M Mahoney, Petra Ross-Macdonald, Long Yuan, Linan Song, Eliseo Veras, Megan Wind-Rotolo, David F McDermott, F Stephen Hodi, Toni K Choueiri, Gordon J Freeman

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003527; DOI: 10.1136/jitc-2021-003527
Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy
Priya Rangan, Anna Mondino

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004147; DOI: 10.1136/jitc-2021-004147
Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer
Ingunn M Stromnes, Ayaka Hulbert, Meagan R Rollins, Ryan S Basom, Jeffrey Delrow, Patrick Bonson, Adam L Burrack, Sunil R Hingorani, Philip D Greenberg

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003525; DOI: 10.1136/jitc-2021-003525
Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?
Roger Sun, Théophraste Henry, Adrien Laville, Alexandre Carré, Anthony Hamaoui, Sophie Bockel, Ines Chaffai, Antonin Levy, Cyrus Chargari, Charlotte Robert, Eric Deutsch

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004848; DOI: 10.1136/jitc-2022-004848
CD40×HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer
Weilin Sun, Xi Wang, Daohan Wang, Li Lu, Hai Lin, Zhaoxiong Zhang, Yangpu Jia, Xinyang Nie, Tong Liu, Weihua Fu

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e005063; DOI: 10.1136/jitc-2022-005063
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer
Philipp Busenhart, Ana Montalban-Arques, Egle Katkeviciute, Yasser Morsy, Chiara Van Passen, Larissa Hering, Kirstin Atrott, Silvia Lang, Jesus Francisco Glaus Garzon, Elisabeth Naschberger, Arndt Hartmann, Gerhard Rogler, Michael Stürzl, Marianne Rebecca Spalinger, Michael Scharl

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003465; DOI: 10.1136/jitc-2021-003465
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling
Samantha M Fix, Marie-Andrée Forget, Donastas Sakellariou-Thompson, Yunfei Wang, Tamara M Griffiths, Minjung Lee, Cara L Haymaker, Ana Lucía Dominguez, Rafet Basar, Christopher Reyes, Sanjay Kumar, Larissa A Meyer, Patrick Hwu, Chantale Bernatchez, Amir A Jazaeri

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e003750; DOI: 10.1136/jitc-2021-003750
Targeting of the alpha_v beta₃ integrin complex by CAR-T cells leads to rapid regression of diffuse intrinsic pontine glioma and glioblastoma
Dustin A Cobb, Jacopo de Rossi, Lixia Liu, Erin An, Daniel W Lee

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003816; DOI: 10.1136/jitc-2021-003816
Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature
Abigail Wong-Rolle, Qiang Dong, Yunhua Zhu, Prajan Divakar, Jyh Liang Hor, Noemi Kedei, Madeline Wong, Desiree Tillo, Elizabeth A Conner, Arun Rajan, David S Schrump, Chengcheng Jin, Ronald N Germain, Chen Zhao

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004698; DOI: 10.1136/jitc-2022-004698
Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy
Huanpeng Chen, Yuying Yang, Yuqing Deng, Fengjiao Wei, Qingyu Zhao, Yongqi Liu, Zhonghua Liu, Bolan Yu, Zhaofeng Huang

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003737; DOI: 10.1136/jitc-2021-003737

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages